Ensuring Sound Bioanalytical Methods Transfer

Publication
Article
BioPharm InternationalBioPharm International-09-15-2014
Volume 2014 eBook
Issue 3

A Q&A on bioanalytical method integrity with Roger Hayes of MPI Research.

 

A Q&A on bioanalytical method integrity with Roger Hayes of MPI Research.

 

Read this article

from BioPharm International’s 2014 Outsourcing Strategies eBook.

View other articles in the 

2014 Outsourcing Strategies eBook

.

 

 

 

 

 

Articles in this issue
BPsupp0914_Pricing_200.jpg
Biopharma Contract Manufacturing Prices Go Up—and Down
BPsupp0914_MPI_TechTransfer_200.jpg
Ensuring Sound Bioanalytical Methods Transfer
BPsupp0914_Feature_CMO_200.jpg
CMOs Gear Up for Biologics Manufacturing Challenges
BPsupp0914_PPD_200.jpg
Weighing Clinical Trial Outsourcing Options
BPsupp0914_JLL_RealEstate_200.jpg
Global Biopharma Industry Shifts Echoed in Real Estate and Facilities Clusters
BPsupp0914_LangerR2_200.jpg
Outsourcing Trends in Biopharmaceutical Manufacturing
Recent Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Enosium Life Science Acquires Rweality in Strategic Transaction

Feliza Mirasol
April 9th 2025
Article

The acquisition of Rweality will strengthen Enosium Life Science’s market access and medical-economic development strategies.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 25th 2023
Podcast

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Liquid obtained in the fermentation process. Microbiologist with test tubes in his hands. Chemical laboratory equipment. Laboratory bioreactor for the production of vaccines. Pharmacology. | Image Credit: © Grispb – © Grispb - stock.adobe.com

Investigating Bioreactor Contamination, Modeling Contaminant Introduction, and Ensuring Bioburden Test Reliability

Naveenganesh Muralidharan
April 7th 2025
Article

This paper outlines a systematic approach to detecting contamination through process deviations, including changes in % dissolved oxygen, pH, and metabolic patterns.

Unidentified microbiologist is place the petri dish and tubes into incubator to incubate the culture of bacteria or fungi growth in appropriate condition, concept of microbial laboratory. | Image Credit: © Sukjai Photo – © Sukjai Photo – Stock.Adobe.com

Evolving Cleanroom Procedures and Sterility Challenges

Feliza Mirasol
April 4th 2025
Article

The shift toward personalized medicines poses new challenges in cleanroom protocols.

Business cooperation strategy to create value for customers achieve the goal. | Image Credit: © Thanadon88 - stock.adobe.com

Adopting Flexible Strategies to Combat Capacity Shortages

Patrick Lavery
April 3rd 2025
Article

More and more contract manufacturers have been looking not at what the state of the supply chain is right now, but what it may be in the next three to five years.

INTERPHEX 2025: Protecting Parenterals in Vials and Syringes with Functional Labels

INTERPHEX 2025: Protecting Parenterals in Vials and Syringes with Functional Labels

Patrick Lavery;Feliza Mirasol
April 2nd 2025
Article

Speaking at INTERPHEX 2025, William Wainwright, business development manager at Iwata Label USA, discusses the practical benefits of functional labels in protecting parenteral drugs.

© 2025 MJH Life Sciences

All rights reserved.